Press release
India Pharmaceutical Excipients Market is Projected to Surpass USD 2032.69 Million By the End of 2030 with a Growing CAGR of 16.31% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1349
Inactive Excipients Crucial for Formulation Development
Inactive excipients, playing a pivotal role in formulation development alongside active ingredients, structure a significant portion of dosage forms in pharmaceutical industries. The rise in demand for accessible medication, coupled with the considerable growth of generic drug production in India, is expected to drive the demand for pharmaceutical excipients in the country.
Modernization of Indian Pharmaceutical Industries
To meet Good Manufacturing Practices (GMP) and international standards, the Indian pharmaceutical industry is undergoing rapid modernization and transformation. Large companies are increasingly sourcing excipients from India, considering it an attractive source for commodity or non-functional excipients.
Contract Manufacturing Sector's Steady Rise
India has emerged as a strong pharmaceutical base with a growing contract manufacturing sector, currently expanding at a remarkable rate of 20%. The sector's progress, driven by the presence of multinational pharmaceutical organizations, is fueling the demand for active ingredients and essential excipients such as diluents, fillers, binders, disintegrants, lubricants, coloring agents, and preservatives.
Challenges and Opportunities in Excipient Manufacturing
While India excels in API Manufacturing, stringent regulations pose challenges for excipient manufacturing. The need for new excipients continues to grow, especially with advancements in novel drug delivery systems and biotechnology-derived drugs. The establishment of the International Excipient Council (IPEC) India aims to promote the excipient industry in the country, acting as a knowledge base and resource center.
Global Dominance in Generic Drug Production
India's pharmaceutical industry is recognized as the "pharmacy of the world," contributing to 40% of the United States' generic demand. The country's ability to produce affordable generic drugs positions it as a major player globally. The surge in generic drug production further emphasizes the crucial role of inactive excipients in formulation development.
Contract Manufacturing Opportunities and Challenges
The growing contract manufacturing industry in India presents opportunities for small and medium enterprises (SMEs) to capitalize on the expanding sector. Outsourcing critical processes offers advantages such as cost savings, expertise, speed, flexibility, and the ability to focus on core competencies. The cost advantages, coupled with resources like a skilled workforce and WHO-GMP approved production premises, make India an attractive outsourcing destination.
Compliance Challenges and Development of Novel Excipients
The implementation of guidelines for ascertaining good manufacturing practice for excipients poses initial challenges for compliance. However, this opens doors for the development of novel excipients in the market. The pharmaceutical industry is focusing on multifunctional excipients to enhance solubility, absorption, disintegration, and stability for parenteral formulations.
Opportunities in Novel Drug Delivery Systems
The growing development of novel pharmaceutical excipients presents burgeoning opportunities in the market. Excipients designed to be biologically inactive remove barriers and offer a low-risk solution to the current shortage of new drug formulations. Nanotechnology-enabled and liposomal delivery systems, along with co-processed excipients, are gaining significance in the market.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/1349
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Pharmaceutical Excipients Market Highlights
2.2. Pharmaceutical Excipients Market Projection
2.3. Pharmaceutical Excipients Market Regional Highlights
Chapter 3. Global Pharmaceutical Excipients Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Pharmaceutical Excipients Market
3.4. Porter's Five Forces Analysis
3.5. IGR-Growth Matrix Analysis
3.5.1. IGR-Growth Matrix Analysis by Type
3.5.2. IGR-Growth Matrix Analysis by Functionality
3.5.3. IGR-Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Pharmaceutical Excipients Market
Chapter 4. Pharmaceutical Excipients Market Macro Indicator Analysis
Chapter 5. Global Pharmaceutical Excipients Market by Type
5.1. Organic
5.2. Inorganic
Chapter 6. Global Pharmaceutical Excipients Market by Functionality
6.1. Binders & Fillers
6.2. Coating Agents
6.3. Disintegrants
6.4. Flavoring Agents and Colorants
6.5. Lubricants and Glidants
6.6. Sweeteners
6.7. Preservatives & Antioxidants
6.8. Others
Chapter 7. Global Pharmaceutical Excipients Market by Region 2023-2030
7.1. North America
7.1.1. North America Pharmaceutical Excipients Market by Type
7.1.2. North America Pharmaceutical Excipients Market by Functionality
7.1.3. North America Pharmaceutical Excipients Market by Country
7.2. Europe
7.2.1. Europe Pharmaceutical Excipients Market by Type
7.2.2. Europe Pharmaceutical Excipients Market by Functionality
7.2.3. Europe Pharmaceutical Excipients Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Pharmaceutical Excipients Market by Type
7.3.2. Asia-Pacific Pharmaceutical Excipients Market by Functionality
7.3.3. Asia-Pacific Pharmaceutical Excipients Market by Country
7.4. RoW
7.4.1. RoW Pharmaceutical Excipients Market by Type
7.4.2. RoW Pharmaceutical Excipients Market by Functionality
7.4.3. RoW Pharmaceutical Excipients Market by Sub-region
Chapter 8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Pharmaceutical Excipients Market
8.2. Companies Profiles
8.2.1. BASF SE
8.2.2. Evonik Industries
8.2.3. Ashland Global Holdings Inc.
8.2.4. Dow Chemical Company
8.2.5. Roquette Frères.
8.2.6. Kerry Group PLC
8.2.7. Associated British Foods plc
8.2.8. lubrizol chemical company
8.2.9. Archer-Daniels-Midland Co
8.2.10. Croda Industrial Chemical
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/1349
Reasons to Buy this Report:
=> Comprehensive analysis of regional markets of India pharmaceutical excipients.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release India Pharmaceutical Excipients Market is Projected to Surpass USD 2032.69 Million By the End of 2030 with a Growing CAGR of 16.31% | Infinium Global Research here
News-ID: 3282704 • Views: …
More Releases from Infinium Global Research LLP
Electric Vehicle Motor Market Outlook 2024-2032: Strong Growth to USD 1451.05 Mi …
✅ Market Overview
The global electric vehicle motor market has been witnessing rapid growth, fueled by rising adoption of battery electric vehicles (BEVs), government incentives, and technological innovations. In 2023, the market was valued at USD 745.23 million, and it is projected to reach USD 1,451.05 million by 2032, expanding at a CAGR of 8.04% between 2024 and 2032.
Electric vehicle motors are at the core of the transition toward sustainable mobility.…
Aircraft Landing Gear Market Growth Driven by Demand, Expected to Reach USD 18.8 …
✅ Market Overview
The global aircraft landing gear market is entering a new phase of steady growth, driven by rising air travel demand, fleet modernization programs, and defense spending. According to recent estimates, the market was valued at USD 14,521.7 million in 2025 and is projected to reach USD 18,822.3 million by 2032, registering a CAGR of 3.81% during 2026-2032.
Landing gear is a vital subsystem in every aircraft, enabling safe takeoff,…
Air Ambulance Services Market Forecast 2026-2032: Strong Growth to USD 10,176.8 …
✅ Market Overview
The global air ambulance services market is gaining strong momentum as healthcare systems worldwide place greater emphasis on rapid emergency response and advanced patient care. In 2025, the market was valued at USD 6,690.1 million and is projected to reach USD 10,176.8 million by 2032, expanding at a CAGR of 6.23% between 2026 and 2032. This growth reflects the rising demand for critical patient transfers, increased medical emergencies,…
Aircraft Maintenance Tooling Market Valued at USD 3761.4 Million in 2025, Projec …
✅ Overview of the Aircraft Maintenance Tooling Market
The global aircraft maintenance tooling market was valued at USD 3,761.4 million in 2025 and is projected to reach USD 4,634.6 million by 2032, growing at a CAGR of 3.07% between 2026 and 2032. This market plays a critical role in aviation, as it supplies the precision instruments and tools necessary for safe, efficient, and timely aircraft maintenance. From wrenches and safety wire…
More Releases for Excipient
Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Albumin Excipient Market Size Growth Forecast: What to Expect by 2025?
The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of…
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater…
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market…
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197
Market Analysis:
Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical…
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,…
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027.
The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and…
